66 related articles for article (PubMed ID: 24782083)
1. Effect of atorvastatin on vascular endothelial function in moderately nicotine-dependent smokers.
Cao XZ; Luo ZR; Zhang HM; Cai JQ
Genet Mol Res; 2014 Apr; 13(2):2698-702. PubMed ID: 24782083
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin normalizes endothelial function in healthy smokers.
Agewall S; Hernberg A
Clin Sci (Lond); 2006 Jul; 111(1):87-91. PubMed ID: 16608440
[TBL] [Abstract][Full Text] [Related]
3. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
Kuryata OV; Yegorova YV
Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
[TBL] [Abstract][Full Text] [Related]
5. Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).
Charbonneau F; Anderson TJ; Title L; Jobin J; Poirier P; Huyhn T; Chan S; Walling A; Hutchison S; Tran T; Lonn E; Buithieu J; Genest J
Atherosclerosis; 2008 Mar; 197(1):420-7. PubMed ID: 17673219
[TBL] [Abstract][Full Text] [Related]
6. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
[TBL] [Abstract][Full Text] [Related]
9. Effect of atorvastatin on impaired vascular function in healthy old men.
Weverling-Rijnsburger AW; Blauw GJ; Meinders AE
J Clin Pharm Ther; 2004 Apr; 29(2):157-64. PubMed ID: 15068405
[TBL] [Abstract][Full Text] [Related]
10. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
11. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999
[TBL] [Abstract][Full Text] [Related]
13. Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes.
Akalin A; Temiz G; Akcar N; Sensoy B
Endocr J; 2008 Oct; 55(5):861-6. PubMed ID: 18506090
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Dogra GK; Watts GF; Chan DC; Stanton K
Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.
Tan KC; Chow WS; Tam SC; Ai VH; Lam CH; Lam KS
J Clin Endocrinol Metab; 2002 Feb; 87(2):563-8. PubMed ID: 11836286
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).
Zieve F; Wenger NK; Ben-Yehuda O; Constance C; Bird S; Lee R; Hanson ME; Jones-Burton C; Tershakovec AM
Am J Cardiol; 2010 Mar; 105(5):656-63. PubMed ID: 20185012
[TBL] [Abstract][Full Text] [Related]
17. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC
Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926
[TBL] [Abstract][Full Text] [Related]
18. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.
Nakamura T; Takano H; Umetani K; Kawabata K; Obata JE; Kitta Y; Kodama Y; Mende A; Ichigi Y; Fujioka D; Saito Y; Kugiyama K
Atherosclerosis; 2005 Aug; 181(2):321-7. PubMed ID: 16039286
[TBL] [Abstract][Full Text] [Related]
19. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
[TBL] [Abstract][Full Text] [Related]
20. [Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia].
Tomás JP; Moya JL; Campuzano R; Barrios V; Megías A; Ruiz S; Catalán P; Recarte MA; Muriel A
Rev Esp Cardiol; 2004 Oct; 57(10):909-15. PubMed ID: 15469787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
